Rosiglitazone is an oral medication used in the treatment of type 2 diabetes. It is a thiazolidinedione that improves insulin sensitivity by activating peroxisome proliferator-activated receptor gamma (PPAR-?). By enhancing the body's response to insulin, it helps control blood sugar levels and reduces the risk of complications associated with diabetes.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Rosiglitazone and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Rosiglitazone impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Rosiglitazone-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
